UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d
false
כיטוב פארמה בע"מ
2
380
KITOV PHARMA LTD
Corporation no:
520031238
12724
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
24/10/2020
www.isa.gov.il
www.tase.co.il
Reference:
2020-02-115536
Time of broadcast:
23:08
23:08
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October 2020 KITOV PHARMA LTD. Annual General Meeting of Shareholders
ea128688-6k_kitovpharmaEDGAR4_Bannerless_isa.pdf
זימון אסיפה כללית ליום 3/12/20
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
04/08/2020
Address:
Menachem Begin St, Azrieli Towers Round Tower
132
,
Tel Aviv
6701101
,
Israel
Tel:
03-9333121
,
Fax:
03-5097196
E-mail address:
info@kitovpharma.com
Company site:
www.kitovpharma.com
Previous names of reporting entity:
KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory:
Masas Ludmer Adi
Position of Signatory in the reporting corporation:
Company Controller
Name of Employer Company:
Address:
Menachem Begin Drive
132
,
Tel Aviv
6701101
Telephone:
03-9333121
Facsimile:
03-5097196
E-mail:
adim@kitovpharma.com
1
Israel